REST is a novel prognostic factor and therapeutic target for medulloblastoma

Pete Taylor, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Irene B. Helenowski, Tobey MacDonald, Martin Hasselblatt, Lars Riedemann, Alvaro Laureano, Laurence Cooper, Vidya Gopalakrishnan

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'REST is a novel prognostic factor and therapeutic target for medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences